Pfizer Stock

$25.90

0.60% today

NYSE, Aug 22, 04:45 pm CET

ISIN

US7170811035

Symbol

PFE

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Pfizer Stock price

$25.74

-11.09 30.11% 5Y

NYSE, Closing price Thu, Aug 21 2025

+0.36 1.42%

ISIN

US7170811035

Symbol

PFE

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

$146.3b

Enterprise Value

$194.9b

Net debt

$48.5b

Cash

$13.2b

Shares outstanding

5.7b

Valuation (TTM | estimate)

P/E

13.7 | 8.5

P/S

2.3 | 2.3

EV/Sales

3.1 | 3.1

EV/FCF

15.7

P/B

1.7

Dividends

DPS

$1.69

Yield 1Y | 5Y

6.6% | 4.2%

Growth 1Y | 5Y

2.4% | 4.1%

Payout 1Y | 3Y

119.9% | 68.3%

Increased

15 Years

Financials (TTM | estimate)

Revenue

$63.8b | $63.2b

EBITDA

$23.3b | $25.8b

EBIT

$18.2b | $21.9b

Net Income

$10.8b | $17.2b

Free Cash Flow

$12.4b

Growth (TTM | estimate)

Revenue

13.5% | -0.7%

EBITDA

45.0% | 17.1%

EBIT

65.4% | 30.9%

Net Income

514.3% | 114.4%

Free Cash Flow

158.5%

Financial Health

Equity Ratio

41.3%

Return on Equity

9.1%

ROCE

10.8%

ROIC

11.5%

Debt/Equity

0.7

EPS

$1.9

FCF per Share

$2.2

Short interest

1.9%

Employees

81k

Rev per Employee

$790.0k

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Get Started for Free Today

Pfizer Stock Analysis

Unlock Scores for Free

??

28 Analysts have issued a Pfizer forecast:

11x Buy

39%

16x Hold

57%

More details on Analyst Estimates Including Price Targets

28 Analysts have issued a Pfizer forecast:

Buy

39%

Hold

57%

Sell

Analyst Estimates with Stock Price Targets

Financial data from Pfizer

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	63,833 63,833	14% 14% 100%
- Direct Costs	16,621 16,621	5% 5% 26%
Gross Profit	47,212 47,212	17% 17% 74%
- Selling and Administrative Expenses	13,896 13,896	6% 6% 22%
- Research and Development Expense	10,204 10,204	4% 4% 16%
EBITDA	23,297 23,297	45% 45% 36%
- Depreciation and Amortization	5,093 5,093	1% 1% 8%
EBIT (Operating Income) EBIT	18,204 18,204	65% 65% 29%
Net Profit	10,752 10,752	514% 514% 17%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Pfizer Stock News

Positive

The Motley Fool

●

about 7 hours ago

My 5 Favorite Stocks to Buy Right Now

Is your portfolio getting thinned out by all the profit-taking that tends to materialize when the market reaches record highs? That's OK.

Positive

Investors Business Daily

●

one day ago

Low Volatility Calls For This Breakout Trade On Pfizer Stock

Pfizer stock currently trades at very low volatility. That could mean it's ripe for a breakout trade, like a long strangle.

Positive

Seeking Alpha

●

one day ago

Pfizer: Shares Are Cheap, But They Could Get Even Cheaper Next Year

I remain bearish on Pfizer due to pricing pressures from IRA/340B and a looming 2026 patent cliff, despite Q2 2025 earnings beat. Cost-cutting measures have lifted EPS above expectations and could deliver $7.7B in savings by 2027, but in my view, these are not a substitute for topline growth. IRA Part D redesign and 340B discounts are already pressuring sales (e.g., Nurtec flat yoy despite 47% ...

More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office	United States
CEO	Albert Bourla
Employees	81,000
Founded	1849
Website	www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now